Could Inovio Pharmaceuticals Be a Millionaire-Maker Stock?
Inovio Pharmaceuticals (NASDAQ: INO) seemed like it could make millionaires out of many average investors -- and fast -- earlier this year. The clinical-stage biotech company soared 718% from the start of 2020 through its high point in July. Why? Inovio was among the first companies to begin testing a coronavirus vaccine candidate in human trials, and was early to report trial data. As a result, the company found itself among the early leaders of the coronavirus vaccine race.
A lot has happened since then, and it hasn't all been good news. Inovio's stock has suffered a 52% decline from its July peak. So is Inovio still a stock that could turn a thousand-dollar investment into a million? Let's take a closer look.
Image source: Getty Images.
Source Fool.com
